Status: Recruiting
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
This is an ongoing evaluation of subjects exposed to ibrexafungerp while pregnant. The study population will include pregnant women of any age.
Participants needed: 100
Trial details
Age: 0+Biological sex: FemaleType: ObservationalSponsor: Scynexis, Inc.Updated: Jul 17, 2024Locations: 1Duration: 1 Year
Eligibility criteria
Exposure to ibrexafungerp during pregnancy or if conception is estimated to have... [+3]
Females who were not exposed to safety study medications during pregnancy [+2]